J Walsh
🏛️ Revolving DoorFormer Government Positions:
LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
Former Legislative Director/Chief Counsel, Sen. John Breaux
🤖
AI Overview
J Walsh has appeared in 922 federal lobbying filings at Farragut Partners LLP, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 28 policy areas.
922
Total Filings
1
Firms
50
Clients
28
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 301 | 33 |
| 2019 | 200 | 30 |
| 2020 | 159 | 33 |
| 2021 | 226 | 39 |
| 2022 | 36 | 19 |
Firms
Farragut Partners LLP922 filings
Top Clients
Southern Company80 filings
Community Oncology Alliance60 filings
Comcast Corporation57 filings
Live Nation Entertainment45 filings
Heron Therapeutics, INC.41 filings
Blue Cross Blue Shield Association40 filings
Edwards Lifesciences, LLC38 filings
Genentech37 filings
Cox Enterprises, INC37 filings
Johnson & Johnson Services INC34 filings
Oneoncology INC.27 filings
Biotechnology Innovation Organization26 filings
AT&T Services INC25 filings
Gilead Sciences INC.24 filings
Omega Flex21 filings
Ambulatory Surgery Center Association20 filings
T-mobile Association16 filings
Astrazeneca Pharmaceuticals LP14 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.